THE BROAD INSTITUTE, INC

The Broad Institute, Inc. specializes in advanced genomic research, large-scale biological data analysis, and precision medicine initiatives, delivering end-to-end research and development services in biotechnology and life sciences. Their core capabilities include high-throughput genome sequencing, multi-omics data integration, cell atlas mapping, and pan-pathogen genomic surveillance, with deep expertise in computational biology, single-cell analysis, and automated laboratory informatics systems. They design and operate centralized omics resource cores that process and analyze complex biological datasets from clinical samples, enabling population-scale studies in neurobiology, hematologic disorders, and infectious disease. Their technical differentiation lies in scalable, reproducible platforms for sequencing, imaging, and data interpretation across diverse cell types and disease models, particularly in induced pluripotent stem cell (iPSC) systems and neurobiological networks. The contractor maintains a consistent, long-standing relationship with the Department of Health and Human Services, primarily supporting the National Institutes of Health through mission-critical research programs. Their work for HHS focuses on large-scale genomic initiatives such as the BRAIN Initiative Cell Atlas Network and Trans-Omics for Precision Medicine, delivering sequencing, data infrastructure, and analytical pipelines that underpin national biomedical research priorities. Their industry focus centers on research and development in biotechnology and life sciences, with strong alignment to testing laboratories and medical diagnostics. They operate at the intersection of genomic science and clinical application, serving as a technical backbone for precision medicine, cellular phenotyping, and pathogen monitoring. Their market positioning is as a high-capacity, mission-driven research partner for federally funded biomedical innovation. The Broad Institute, Inc. is a non-federal entity headquartered in Cambridge, Massachusetts, with no government certifications on record. It operates as a research-focused organization deeply embedded in the U.S. biomedical R&D ecosystem, leveraging academic-industry collaboration to advance national health priorities through scalable scientific infrastructure.